{"task_id": "1acd8811f7c1833c", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 75/464)", "text": "(p. 349)\nPheochromocytoma (p. 349)\n60\nHypertension\n\n--- Page 82 ---\nHyperlipidemia\nCanadian Cardiovascular Society\nDyslipidemia Guidelines 2006\nDIFFERENTIAL DIAGNOSIS OF\nHYPERCHOLESTEROLEMIA\nPRIMARY\npolygenic, familial (suspect when total\ncholesterol\n>6\nmmol/L\n[>232\nmg/dL],\nLDL\n>5 mmol/L [>193 mg/dL])\nSECONDARY\nobesity, diabetes, hypothyroidism,\nnephrotic\nsyndrome,\nmedications\n(estrogen,\ntamoxifen, b blockers, glucocorticoids)\nDIFFERENTIAL DIAGNOSIS OF\nHYPERTRIGLYCERIDEMIA\nPRIMARY\ndietary, familial (suspect when TGL\n>5 mmol/L [>440 mg/dL])\nSECONDARY\nobesity, diabetes, nephrotic syn\ndrome, hypothyroidism, alcoholism, drugs (tamox\nifen, cyclosporine, glucocorticoids)\nDIFFERENTIAL DIAGNOSIS OF LOW HDL\nPRIMARY\nSECONDARY\nobesity, smoking, inactivity\nCLINICAL FEATURES\nTELLTALE SIGNS\nLesions\nI\nIIa\nIIb\nIII\nIV\nV\nTendon xanthoma (LDL)\nX\nPalmer xanthoma\nX\nEruptive xanthoma\nX\nX\nX\nXanthelasma\nX\nX\nX\nX\nX\nX\nTuberous xanthoma\n(LDL)\nX\nX\nX\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCr, fasting glucose, TSH, total chol, TGL,\nLDL, HDL, apoB, Lp(a), CRP, CK, AST, ALT, ALP,\nbilirubin, LDH\nMANAGEMENT\nLIFESTYLE CHANGES\ndiet (\" fruit and vegetable\nintake, \" mono and polyunsaturated fats, # saturated\nfats and trans fatty acid to <7% of calories, \" omega\n3 fatty acid from fish and plant sources, salmon oil\n3 9 g can #TGL). Exercise\nRISK REDUCTION MEDICATIONS\n\u0002\nRESINS (# LDL, \" cholesterol synthesis)\nCholestyr\namine 2 24 g PO daily, colestipol 5 30 g PO daily in\ndivided doses. Main side effects include constipa\ntion, # vitamin K deficiency, and drug interactions\n(bind to other drugs and prevent absorption)\n\u0002 HMG-COA REDUCTASE INHIBITORS (# LDL)\natorvas\ntatin 10 80 mg daily, pravastatin 10 40 mg daily,\nrosuvastatin\n2.5 40\nmg\ndaily,\nsimvastatin\n10 80 mg daily. Main side effects include hepato\ntoxicity, myalgia and myopathy\n\u0002\nFIBRATES (\" HDL, # TGL)\ngemfibrozil 600 1200 mg\ndaily, fenofibrate 67 200 mg daily. Main side\neffects include GI upset, gallstones, and myalgia\n\u0002\nNIACIN (# LDL, \"\" HDL, # TGL)\nnicotinic acid 1 3 g.\nMain side effects include \" blood sugar; flushing,\nhepatotoxicity, and gastric irritation\n\u0002\nASPIRIN\nASA 81 mg PO daily\nTREAT SECONDARY CAUSES/METABOLIC SYN\nDROME IF PRESENT\nTREATMENT TARGETS BASED ON RISK CATEGORY (CCS 2009 Guideline)\nHigh risk\nModerate risk\nLow risk\nLDL\n<2 mmol/L [<77 mg/dL] or \u000550% # LDL\n<2 mmol/L\n[<77 mg/dL] or \u000550% # LDL\n\u000550% # LDL\nApoB\n<0.80 g/L [<80 mg/dL]\n<0.80 g/L\n[<80 mg/dL]\nRISK CATEGORIES\n\u0002\nHIGH\n\u000520% 10 year Framingham risk or estab\nlished CAD, diabetes, CVD, or PVD. All high risk\npatients require treatment\n\u0002\nMODERATE\n10 19% 10 year CAD risk. Consider\ninitiating treatment if LDL >3.5mmol/L [135 mg/\ndL], TChol/HDL >5.0, high sensitivity CRP >2mg/L,\nmen age >50, women age >60, or significant\nfamily history\n\u0002\nLOW\n<10% 10 year CAD risk. Consider initiating\ntreatment if LDL \u00055.0mmol/L [\u0005193mg/dL]\n\u0002\nUTILITY\n10 year risk calculation is based on Fra\nmingham study (gender, age, total chol, HDL, SBP,\nsmoking)\nTREATMENT ISSUES\nTREATMENT ISSUES (CONT\u2019D)\nTREATMENT ISSUES (CONT\u2019D)\nHyperlipidemia\n61", "text_length": 3036, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 75/464)", "type": "chunk", "chunk_index": 74, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.339223", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.339927", "status": "complete", "chunks_added": 2}